Visby Medical, the at-home diagnostics company, today announced U.S. Food and Drug Administration (FDA) clearance for the ...
The hepatitis testing market presents significant opportunities driven by rising hepatitis infections, increasing demand for early diagnosis, and advancements in rapid point-of-care testing. Key ...
WHO's Emergency Use Listing of the Bundibugyo virus test enhances rapid diagnosis amid Africa's ongoing Ebola outbreak.
GlobalData on MSN
FDA clears Visby Medical’s at-home Covid-19 and Influenza PCR test
Visby's multi-viral Medical Flu and Covid-19 test yields results in 30 minutes.
(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...
CDT. Biocartis and Discovery Life Sciences Announce Strategic Collaboration to Advance Precision Oncology Diagnostics. ITASCA ...
Co-Diagnostics Invited to Participate in NPOC Tuberculosis Diagnostics Workshop in Bangkok, Thailand
Workshop brings together national TB programs, researchers, donors, and technical agencies from 21 countries to advance ...
Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...
Peer-reviewed journal Clinical Chemistry published the first head-to-head study comparing GraftAssure™ to industry-leading ...
Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are a significant cause of morbidity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results